Dr. Agarwal's Health Care Limited
₹468.90▼ -8.25 (-1.73%)
AGARWALEYE·NSE·Healthcare
Market Cap
14771.83 Cr
PE Ratio
111.38
Volume
1,00,361
Day High - Low
479.70 - 466.20
52W High-Low
568.00 - 401.00
₹468.90▼ -8.25 (-1.73%)
Market Cap14771.83 Cr
PE Ratio111.38
Volume1,00,361
Day High - Low479.70 - 466.20
52W High-Low568.00 - 401.00
Dr. Agarwal's Health Care Limited (AGARWALEYE): company summary
The company's business is improving, with annual revenue rising 21.6% and net profit growing 52.9% year-over-year.
Dr. Agarwal's Health Care Limited (AGARWALEYE) is a small-cap Healthcare company valued at ₹14,772 crore operating in Hospital on the NSE and BSE.
- Recent price move
- Dr. Agarwal's Health Care Limited last traded at ₹468.9, modestly down 1.73% on the day.
- Recent developments
- On 2026-08-13, TPG and Temasek sold nearly 13% of their stake in Dr Agarwals Health Care for ₹2,008 crore, remaining major public shareholders despite the bulk sale. On 2026-08-12, the stock fell on block deals, alongside other stocks like Tenneco Clean Air India and RHI Magnesita.
- Financial performance
- The company's business is improving, with annual revenue rising 21.6% and net profit growing 52.9% year-over-year. The latest quarter saw revenue increase 26.1% and net profit jump 44.8% compared to the same quarter a year earlier. Net profit margin expanded 1.7 percentage points to 8.1%, while return on equity remained at 6.6%.
- Valuation multiples
- The stock trades at 111.4 times earnings, a premium to the Healthcare median of 32.0, 7.90 times book value.
- Things to watch
- The stock is 14.4% below its 52-week high. Domestic institutional holding fell by 0.11 percentage points in the quarter. The company is not paying dividends despite reporting profits.
- Where it stands
- Dr Agarwals Health Care has shown strong growth in both revenue and profit, with the latest quarter reflecting continued expansion. The company's net profit margin has improved, but its stock price is below its 52-week high. Promoter holding remains at 32.34%, while foreign institutional holding is at 57.96%.
Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
5.3/10
Weak
Fair Value
Sign in to see
ROE
6.58%
Weak
P/E
111.38x
Expensive
Debt / Equity
0.53
Moderate
Industry
Healthcare
Hospital
Overall View
Mixed
Price performance
Day₹466.20
₹479.70
52W₹401.00
₹568.00
DocStoX take
Supported by risk (8.4) and growth (7.7), but held back by valuation (0.0). Risk looks strong at 8.4, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence5.3
/10
Weak
Quality
Solid
ROE 6.6%
Valuation
Expensive
P/E 111.4×
Growth
Strong
Revenue +34.6% 5Y CAGR
Risk
Low risk
D/E 0.53
Momentum
Soft
41% of 52-week range
At a glance
Market Cap
₹14,772 Cr
52W High / Low
₹568 / ₹401
Dividend Yield
0.00%
Promoter Holding
32.33%
EPS (TTM)
₹4.21
Book Value
₹63.94
Key highlights
- Revenue compounding 35% a year
- Profitable in all of the last 5 years
- Profit compounding 18% a year
- Valuation is weak (0.0/10)
- Expensive at 111× earnings
3 Positives2 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Hospital
Explore Dr. Agarwal's Health Care Limited’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Dr. Agarwal's Health Care Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Dr. Agarwal's Health Care Limited with peers
Dr. Agarwal's Health Care Limited vs Sun Pharmaceutical Industries LimitedDr. Agarwal's Health Care Limited vs Divi's Laboratories LimitedDr. Agarwal's Health Care Limited vs Torrent Pharmaceuticals LimitedDr. Agarwal's Health Care Limited vs Apollo Hospitals Enterprise LimitedDr. Agarwal's Health Care Limited vs Zydus Lifesciences LimitedDr. Agarwal's Health Care Limited vs Laurus Labs Limited
Related tools & concepts
Value Dr. Agarwal's Health Care Limited with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing